WFG Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$506K Buy
6,147
+623
+11% +$50.8K 0.11% 200
2017
Q1
$465K Sell
5,524
-1,189
-18% -$95.2K 0.12% 182
2016
Q4
$494K Buy
6,713
+5,642
+527% +$420K 0.12% 207
2016
Q3
$86K Sell
1,071
-25
-2% -$2K 0.02% 561
2016
Q2
$86K Sell
1,096
-219
-17% -$16.5K 0.02% 537
2016
Q1
$95K Sell
1,315
-16
-1% -$1.21K 0.03% 480
2015
Q4
$112K Sell
1,331
-141
-10% -$11.7K 0.03% 436
2015
Q3
$123K Buy
1,472
+459
+45% +$38.8K 0.04% 408
2015
Q2
$85K Sell
1,013
-744
-42% -$56.7K 0.02% 579
2015
Q1
$128K Sell
1,757
-9,388
-84% -$668K 0.04% 456
2014
Q4
$769K Sell
11,145
-2,504
-18% -$169K 0.16% 148
2014
Q3
$885K Buy
13,649
+19
+0.1% +$1.2K 0.17% 150
2014
Q2
$847K Buy
13,630
+20
+0.1% +$1.19K 0.16% 156
2014
Q1
$801K Sell
13,610
-1,202
-8% -$67.1K 0.16% 160
2013
Q4
$755K Sell
14,812
-108
-0.7% -$5.41K 0.11% 218
2013
Q3
$751K Sell
14,920
-1,017
-6% -$53.2K 0.12% 204
2013
Q2
$783K Buy
+15,937
New +$867K 0.13% 189

Other funds holding LLY

WFG Advisors's LLY Position: Q2 2017 in Review

WFG Advisors increased its Eli Lilly (LLY) stake by 11% in Q2 2017, buying an estimated $50.8K and bringing the position to 6,147 shares worth $506K. The position accounts for 0.11% of the portfolio, ranked #200.

WFG Advisors first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. The position peaked at $885K in Q3 2014. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • WFG Advisors held 6,147 shares of Eli Lilly worth $506K as of Q2 2017.
  • WFG Advisors bought 623 Eli Lilly shares in Q2 2017, an estimated $50.8K.
  • Eli Lilly made up 0.11% of WFG Advisors's portfolio in Q2 2017, its #200 holding.
  • WFG Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
  • WFG Advisors's Eli Lilly position peaked at $885K in Q3 2014.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.